Boston Scientific Launches the HeartLogic™* Heart Failure Diagnostic in Europe - Seite 2

At the Heart Failure Congress 2018 in Vienna (May 26-29), several new analyses from the MultiSENSE Study have been presented. The data revealed that HeartLogic may detect changes in rapid shallow breathing patterns and may thus enable better outcomes for HF patients:

• Changes in the Rapid Shallow Breathing Index (RSBI) correlated with changes in patients' dyspnoeic status. For example, increased rapid shallow breathing resulted in a worsening dyspnoea status whereas minute ventilation (MV), a common marker known to be elevated in HF patients, did not.^[6]
• The device-measured RSBI showed to be significantly elevated in the three-day period preceding HF events, whereas MV did not show significant differences.^[7]
• Readmissions or death were more likely when the device-measured RSBI worsened during heart failure hospitalisation.^[8]

In addition:

• HeartLogic has proven robust to various patient demographics. The algorithm works effectively across different patient body types and for patients of different ethnicities.
• Analysis of heart sound recording during echo evaluation in a patient with atrial fibrillation (AF) confirmed the presence of the third heart sound (S3). A device-based objective measure may thus provide more consistent assessment of S3 than auscultation in the midst of an arrhythmic rumble of AF.

Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood through to the cells of the body. This can result in symptoms including fatigue, breathing problems or coughing. Managing HF can involve multiple hospitalisations, which can have an adverse impact on patient outcomes and quality of life. Nearly half of patients (46%) are re-hospitalised for heart failure within 60 days.^[7]

For more information, please visit: http://www.bostonscientific.com/en-EU/medical-specialties/electrophysiology/heart-logic.html

About the HeartLogic™ Heart Failure Diagnostic
The HeartLogic™ Heart Failure Diagnostic is a validated diagnostic tool to detect gradual worsening of heart failure (HF) over days or weeks. HeartLogic incorporates multiple sensors and combines trend data into one composite index, sending clinicians a single actionable alert and detailed report when it crosses a clinician-set threshold. This index allows physicians to detect early warning signs of HF symptoms worsening, giving them time to address the pathophysiological aspects of HF, adjust the treatment and avoid potential re-hospitalisations.